COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Receives Positive Opinion for Orphan Drug Designation in the European Union for WVE-210201

02/07/2018 - 14:00

Investigational WVE-210201 in development for treatment of Duchenne muscular dystrophy patients amenable to exon 51 skipping Patients currently enrolling in global Phase 1 clinical trial CAMBRIDGE, Mass., July 02, 2018 [...]

Immutep Submits Investigational New Drug (IND) Application With FDA

02/07/2018 - 14:00

SYDNEY, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or “the Company”) is pleased to announce that it has submitted its Investigational New Drug (“IND”) application to [...]

Quotient Limited Announces Completion of Senior Secured Notes Offering

02/07/2018 - 14:00

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million aggregate principal [...]

PolarityTE Adds Peter Cohen, Former Board Member of the NYSE and Chairman and CEO of Cowen Inc., to the Board of Directors

02/07/2018 - 14:00

SALT LAKE CITY, July 02, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that Peter Cohen will join PolarityTE’s Board of Directors. Mr. Cohen is well known within the investment community having [...]

Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain

02/07/2018 - 14:00

Review of Real World Cases from Five Independent Sites Across Europe Demonstrated Reduction in Pain Scores and General Improvement of Health Metrics up to 6 Months Following Treatment as Evidenced by VAS BACK , ODI and [...]

SeaSpine Names Dennis L. Cirino Senior Vice President, Spinal Systems

02/07/2018 - 14:00

CARLSBAD, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]

Novo Nordisk A/S - Share repurchase programme

02/07/2018 - 13:53

Bagsværd, Denmark, 2 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Nuvectra Provides Update on FDA and TÜV SÜD Review of Virtis™ PMA and CE Mark Applications

02/07/2018 - 13:30

PLANO, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration (FDA) pre-market approval [...]

Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis

02/07/2018 - 13:30

SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the publication 1 of results from preclinical studies of its pan-caspase inhibitor emricasan, demonstrating [...]

Transactions under Novozymes’ stock buyback program

02/07/2018 - 13:28

Please read the full announcement in the attached PDF Attachment 2018_41_Stock_Buybackprogram_EN

BrightGuard Installs Free Sunscreen Dispensers at New York City Public Pools and Beaches

02/07/2018 - 13:00

First-of-its-Kind Automated Sunscreen Dispenser Company Teams with Coppertone® and IMPACT Melanoma to Provide Free, High-Quality Sunscreen to Help Reduce NYC’s Risk of Skin Cancer NEW YORK and NEWPORT BEACH, Calif., [...]

RedHill Biopharma Announces Allowance of Two New RHB-104 Patents Ahead of Top-Line Phase III Results for Crohn’s Disease

02/07/2018 - 13:00

RedHill has received Notices of Allowance for two new patents covering RHB-104 in the U.S. and Europe which are expected to be valid until at least 2029, once granted Top-line results from the first Phase III study with [...]

Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors

02/07/2018 - 12:30

Collaboration with Xiangxue Pharmaceutical Expands Portfolio in to TCR-T Immunotherapy In-Licensing of a Biologic Product from Avalon BioMedical Management BUFFALO, N.Y., July 02, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc [...]

PotNetwork Holdings, Inc. Changing Name To Biotech Hemp, Inc. and Moves Forward on Filings In Preparation for Uplisting

02/07/2018 - 12:00

Company to Rapidly Complete FINRA Application, and Form 10 To Become Fully Reporting SEC Issuer FT LAUDERDALE, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) [...]

Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease

02/07/2018 - 12:00

NEW YORK and MELBOURNE, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced a US$50 million financing from NovaQuest Capital Management, L.L.C. (NovaQuest) for the [...]

Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains

02/07/2018 - 11:30

Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has completed an allergy [...]

Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment

02/07/2018 - 11:30

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 MELBOURNE, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

02/07/2018 - 09:30

FIT Biotech Oy Company release July 2, 2018 at 10:30 am EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech Oy ( [...]

Dr. Deborah Dunsire named new President and CEO of Lundbeck

02/07/2018 - 09:17

Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire will take up her [...]